News Home

Is Calithera Biosciences Inc (CALA) a Winner in the Biotechnology Industry?

Thursday, August 18, 2022 01:50 PM | InvestorsObserver Analysts
Is Calithera Biosciences Inc (CALA) a Winner in the Biotechnology Industry?

Calithera Biosciences Inc (CALA) is around the middle of the Biotechnology industry according to InvestorsObserver. CALA received an overall rating of 58, which means that it scores higher than 58 percent of all stocks. Calithera Biosciences Inc also achieved a score of 60 in the Biotechnology industry, putting it above 60 percent of Biotechnology stocks. Biotechnology is ranked 29 out of the 148 industries.

Overall Score - 58
CALA has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on CALA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 58 would rank higher than 58 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Calithera Biosciences Inc Stock Today?

Calithera Biosciences Inc (CALA) stock is trading at $4.87 as of 1:49 PM on Thursday, Aug 18, an increase of $0.41, or 9.19% from the previous closing price of $4.46. The stock has traded between $4.46 and $4.95 so far today. Volume today is below average. So far 54,311 shares have traded compared to average volume of 110,656 shares. Click Here to get the full Stock Report for Calithera Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App